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Abstract
Background: The two-component NS2B-NS3 proteases of West Nile and dengue viruses are essential for viral replication
and established targets for drug development. In all crystal structures of the proteases to date, the NS2B cofactor is located
far from the substrate binding site (open conformation) in the absence of inhibitor and lining the substrate binding site
(closed conformation) in the presence of an inhibitor.
Methods: In this work, nuclear magnetic resonance (NMR) spectroscopy of isotope and spin-labeled samples of the West
Nile virus protease was used to investigate the occurrence of equilibria between open and closed conformations in solution.
Findings: In solution, the closed form of the West Nile virus protease is the predominant conformation irrespective of the
presence or absence of inhibitors. Nonetheless, dissociation of the C-terminal part of the NS2B cofactor from the NS3
protease (open conformation) occurs in both the presence and the absence of inhibitors. Low-molecular-weight inhibitors
can shift the conformational exchange equilibria so that over 90% of the West Nile virus protease molecules assume the
closed conformation. The West Nile virus protease differs from the dengue virus protease, where the open conformation is
the predominant form in the absence of inhibitors.
Conclusion: Partial dissociation of NS2B from NS3 has implications for the way in which the NS3 protease can be positioned
with respect to the host cell membrane when NS2B is membrane associated via N- and C-terminal segments present in the
polyprotein. In the case of the West Nile virus protease, discovery of low-molecular-weight inhibitors that act by breaking
the association of the NS2B cofactor with the NS3 protease is impeded by the natural affinity of the cofactor to the NS3
protease. The same strategy can be more successful in the case of the dengue virus NS2B-NS3 protease.
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Introduction
West Nile virus (WNV) is a flavivirus related to yellow fever
virus, dengue virus, and Japanese encephalitis virus all of which
cause human diseases. During infection, the flavivirus RNA
genome is translated into a polyprotein comprising of three
structural and seven non-structural proteins [1]. The N-terminal
part of nonstructural protein 3 (NS3) encodes a serine protease
that cleaves the polyprotein into several components. The activity
of the NS3 protease (NS3pro) is greatly enhanced by covalent
tethering of about 40 residues from the membrane-bound NS2B
protein that acts as a co-factor. NS3 is essential for viral replication
making it an attractive drug target [2–4]. The C-terminal part of
NS3 contains a nucleotide triphosphatase, an RNA triphospha-
tase, and a helicase which have only little influence on the protease
activity [5].
Crystal structures of WNV NS2B-NS3pro in the absence of
inhibitor [6] and in the presence of tetra- and tripeptide inhibitors
[7,8] or bovine pancreatic trypsin inhibitor (BPTI) [6] have been
determined. The fold of NS2B is very different in the presence of
inhibitors from that in the absence of inhibitor (Figure 1). In all
structures, the N-terminal segment of NS2B (residues 52–58)
inserts into a b-sheet formed by NS3pro. In the presence of
inhibitor, the C-terminal segment (CTS) of NS2B wraps around
NS3pro, bringing the C-terminal b-hairpin of the NS2B cofactor
in close proximity of the active site. This fold is referred to in the
following as the closed conformation. In the absence of inhibitor,
the NS2B CTS is located at a very different position far from the
active site of the protease. We refer to this fold and any other
conformation, where NS2B is disengaged from the substrate
binding site, as open conformations. As the NS2B CTS is essential
for full catalytic activity of WNV NS2B-NS3pro [2,9] the closed
www.plosntds.org 1 December 2009 | Volume 3 | Issue 12 | e561conformation appears to be a prerequisite for full proteolytic
activity.
The fold of the corresponding protease from the closely related
dengue virus type 2 (DENV) NS2B-NS3pro construct was also
determined by X-ray crystallography in the absence of an inhibitor
[7]. NS2B without the CTS results in an inactive protease
suggesting that this part of the cofactor forms part of the active site
[7]. The fold observed in DENV is remarkably similar to the open
conformation of WNV NS2B-NS3pro, suggesting that the open
conformation may be the predominant species in solution
(Figure 1). Alternatively, the open conformation may be a
crystallographic artefact. We undertook the present research in
order to address this issue and also because of the failure of high
throughput drug screens to identify stable low-molecular weight
compounds that bind to the WNV NS2B-NS3 protease specifically
and with subnanomolar affinity [10–15]. Better understanding of
the dynamics of the NS2B cofactor of the protease could be the
key towards the design of improved inhibitors and has important
implications for the conformational space accessible to the
protease when bound to the host cell membrane.
In the following, we present an NMR analysis of the
conformational equilibria of the WNV NS2B-NS3 protease in
the absence and presence of inhibitors.
Methods
Materials
1-oxyl-2,2,5,5-tetramethyl-D3-pyrroline-3-methyl) methane thio-
sulfonate (MTSL) was purchased from Toronto Research Chem-
icals (North York, Ontario, Canada). Compound 1 (Figure 2) was
obtained from Maybridge (Tintagel, UK). Compound 2 was
synthesized in-house. The West Nile virus protease construct used
contained NS2B covalently linked to NS3pro via a Gly4-Ser-Gly4
linker[16] asused forcrystallization[7].Inaddition,Lys96ofNS2B
was mutated to alanine to prevent self-cleavage of the protease [17].
In the following, this construct and the unmutated wild type are
referred to as NS2B-NS3pro and wt NS2B-NS3pro, respectively. A
second construct containing the additional mutation N89C at the
C-terminus of NS2B was prepared to provide a thiol group for the
attachment of a spin-label. This construct is referred to as NS2B-
NS3pro
C. The N89C mutation was made by site-directed
mutagenesis using PCR. Uniformly
15N/
13C- and
15N-labeled
protein samples of NS2B-NS3pro and five combinatorially
15N-
labeled samples of the NS2B-NS3 protease without the K96A
mutation were prepared as described previously [18]. In vivo protein
yields were about 9 mg of purified protein per litre of medium. The
selectively
15N-Ile labeled sample was prepared by cell-free protein
synthesis as described previously [18,19].
Spin Labeling
The nitroxide radical tag [(1-oxyl-2,2,5,5-tetramethyl-D3-pyrro-
line-3-methyl) methane thiosulfonate, MTSL] was used for spin-
labeling. A 0.3 mM solution of NS2B-NS3pro
C in 0.5 ml reaction
buffer (50 mM Tris, pH 7.6) was treated with 5 equivalents of DTT
Figure 1. Crystal structures of the West Nile and dengue NS2B-NS3 proteases. NS2B is shown in magenta, with the N- and C-termini
labeled. The polypeptide chain of NS3 is shown in rainbow colors ranging from blue (N-terminus) to red (C-terminus). Full-length NS2B comprises 131
residues [1]. All constructs used in crystal structure determinations include the NS2B cofactor segment and exclude the N-terminal 48 and C-terminal
35 residues of NS2B which contain hydrophobic membrane anchors. The constructs used in the present work closely resembled the constructs used
for crystallography. In denoting residues 49–60 as the N-terminal segment (NTS) of NS2B and residues 75–96 as the C-terminal segment (CTS) of
NS2B, we refer to the cofactor segment of NS2B only. (A) WNV NS2B-NS3pro in the presence of the inhibitor BPTI (PDB accession code 2IJO). The
substrate binding site is indicated by the BPTI segment Pro13-Arg17 shown in black. The location of the active-site histidine is labeled with a blue
star. (B) WNV NS2B-NS3pro in the absence of inhibitors (PDB code 2GGV). (C) Dengue virus NS2B-NS3pro in the absence of inhibitors (PDB code
2FOM). The present text refers to the protein fold in (A) as closed conformation, while the folds in (B) and (C) are referred to as open conformations.
doi:10.1371/journal.pntd.0000561.g001
Author Summary
Dengue and West Nile virus infections put an estimated 2.5
billion people at risk. Neither drugs nor vaccines are
currently available against these diseases. The non-
structural protein NS3 is a protease that, together with
the cofactor NS2B, is essential for viral maturation. The
NS2B-NS3 proteases of dengue and West Nile viruses are
highly homologous and present promising drug targets.
Crystal structures of the West Nile virus protease with and
without bound inhibitor revealed large structural differ-
ences in NS2B, while no crystal structure of the dengue
virus protease could be determined with a bound
inhibitor. We investigated the structural change in solution
and found that the C-terminal segment (CTS) of the NS2B
cofactor is prone to dissociation from NS3. In the case of
the West Nile virus protease, the CTS of NS2B is mostly
associated with NS3, especially in the presence of
inhibitors. In the case of the dengue virus protease and
in the absence of inhibitors, the CTS of NS2B is mostly
dissociated from NS3. Finding drug candidates to inhibit
the association of the NS2B cofactor may thus be easier for
the dengue virus protease.
NMR Analysis of the West Nile Virus Protease
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ultrafilter with a molecular weight cutoff of 5 kD. Reaction buffer
was added to a volume of 4 ml. 30 equivalents of MTSL were
dissolved in 60 ml acetone and the MTSL solution was added
stepwise, mixing the solution well after each addition. The mixture
was stirred at room temperature for about 12 hours and
subsequently centrifuged to remove undissolved MTSL, followed
by concentration to 0.3 ml and washing with 20 mM Tris, pH 7.2.
NMR Spectroscopy
All NMR spectra were recorded at 25uCo nB r u k e r6 0 0a n d
800 MHz NMR spectrometers equipped with cryoprobes.
15N-
HSQC spectra of the combinatorially
15N-labeled samples were
recorded in a 20 mM HEPES buffer (pH 7.0) containing 1 mM
TCEP.
15N-HSQC spectra of a 0.26 mM solution of uniformly
15N-
labeled NS2B-NS3pro
C derivatized with MTSL were recorded in
2 0m MT r i s ,p H7 . 2 ,u s i n gt h e8 0 0M H zN M Rs p e c t r o m e t e rw i t h
t1max=25ms and t2max=73 ms. Inhibitor 2 was added to a final
concentration of 0.6 mM by adding 3 ml of a 100 mM stock solution
in DMSO-d6. A 20 mM stock solution of inhibitor 1 in 50% H2O/
50% DMSO-d6wasusedforpreparing samples containing inhibitor 1.
15N-relaxation rates R2 were measured at a
1H NMR frequency
of 600 MHz using the CPMG sequence of Farrow et al. [20] with
relaxation delays of 8.8, 17.6, 26.4, 35.2, 44.0, 52.8, 61.6, 70.4,
79.2 and 88.0 ms and a tcp delay between subsequent 180u(
15N)
pulses of 900 ms. The protein concentration was 0.9 mM in
20 mM HEPES, pH 7.2, 2 mM DTT at 298 K. Experiments with
inhibitor were performed with 3 mM inhibitor 2. The data were
analyzed using the program Sparky [21]. The chemical shifts were
deposited in the BioMagResBank (accession code 16359).
Results
Resonance Assignment of NS2B-NS3pro without
Inhibitor
In contrast to NMR spectra in the presence of inhibitors which
allowed virtually complete resonance assignments of the
15N-
HSQC spectra by conventional 3D NMR techniques [18], many
of the cross-peaks in the
15N-HSQC spectrum of NS2B-NS3pro
are broadened beyond detection in the absence of an inhibitor,
making the assignment of the NMR resonances challenging
(Figure S1) [14,15,18]. In order to assign the observable cross-
peaks, we used the previously established resonance assignments of
the
15N-HSQC spectrum of the protease in the presence of
inhibitor 1 (Figure 2) and an inhibitor closely related to inhibitor 2
(compound 1 reported by Su et al. [18]) as a starting point. The Kd
values of the inhibitors are in the 10–100 mM range [13,14]. The
inhibitors were in fast exchange between bound and free state, so
that titration of the protein with inhibitor yielded a series of
15N-
HSQC spectra with continuously shifting cross-peaks, allowing
tracking of the resonance assignments for the resolved cross-peaks.
In addition, combinatorial
15N-labeling established the amino acid
type associated with each cross-peak.
Analysis of
15N-Ile NS2B-NS3pro
As many of the cross-peaks in the
15N-HSQC spectrum of
uniformly
15N-labeled NS2B-NS3pro are overlapped, a selectively
15N-Ile labeled sample was prepared for improved spectral
resolution. The
15N-HSQC spectra of the
15N-Ile labeled sample
changed greatly in appearance upon addition of the inhibitor 1
(Figure 3A). In particular, all isoleucine residues appeared as single
peaks in the presence of 1, whereas many peaks were missing,
significantly shifted or split into several peaks in the absence of
inhibitor. Extreme broadening of some but not all lines is a
hallmark of chemical exchange of a protein subdomain between
different conformations.
Figure 3B shows the locations of the isoleucine residues in the
closed conformation, identifying the residues that were strongly or
only slightly affected by the presence of inhibitor. The isoleucine
residues located in the NS2B CTS or in parts of NS3 in the vicinity
of the NS2B CTS are the isoleucine residues most prone to
conformational heterogeneity. Too many residues are affected to
explain these effects by conformational flexibility of a few active-site
residues. The most plausible explanation is that the NS2B CTS
assumes multiple conformations in the absence of an inhibitor. We
previously reported nuclear Overhauser effects (NOEs)that indicate
that the closed conformation of Figure 3A is the prevailing
conformation in the presence of inhibitor 1 [18]. In the absence
of inhibitor, the closed conformation may still be present but a
conformational equilibrium exists that cannot be with the open
conformation of Figure 3C as the only additional species, as this
would significantly alter the chemical environment of Ile60
NS2B.
The cross-peak of Ile60
NS2B is, however, essentially unperturbed.
Analysis of Uniformly
15N-Labeled NS2B-NS3pro
Comparison of the
15N-HSQC spectra of uniformly
15N-labeled
NS2B-NS3pro confirmed the analysis above. Due to spectral
overlap, the absence of cross-peaks in the sample without inhibitor
could be reliably assessed only for resolved cross-peaks. Nonethe-
less, we could confirm that the absence of inhibitor led to many
missing cross-peaks in the NS2B CTS segment following Glu73
and for segments 73–76, 110–116, 124–130 and 150–153 of NS3
(Figure 3D).
The overall picture is that of extensive dynamics in and around
the substrate binding site including, in particular, the C-terminal
b-hairpin of NS2B. In contrast, cross-peaks were observable in
both states with largely conserved intensities for residues near the
N-terminal segment (NTS) of NS2B, as expected for a stable
association of the NS2B NTS to NS3. Binding of 1 caused
significant chemical shift changes (.0.05 ppm) for a large part of
the protein, highlighting the extent of conformational adjustments
Figure 2. Chemical structures of inhibitors used. Throughout the
text, the inhibitors in the top and bottom panels are referred to as
compounds 1 and 2, respectively.
doi:10.1371/journal.pntd.0000561.g002
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identify excessive line broadening for any peaks observable in the
segment between residues 53 and 72 of NS2B, whereas the data of
Figure 3A–C had identified Ile68 of NS2B as a significantly
affected residue. The combined results suggest that, in contrast to
the crystal structure data, only the CTS of NS2B following Ser72
is prone to dissociation from NS3pro and that the line broadening
of Ile68
NS2B is due to a different effect.
Figure 3. Conformational exchange of NS2B highlighted by inhibitor-induced spectral changes. (A) Superimposition of
15N-HSQC
spectra of a 50 mM solution of selectively
15N-Ile labeled wt NS2B-NS3pro in the presence (blue spectrum) and absence (red spectrum) of 0.3 mM
inhibitor 1. The spectra were recorded at 25uC in a buffer containing 20 mM HEPES, pH 7.0, and 2 mM DTT, using a Bruker 800 MHz NMR
spectrometer. The sequence-specific resonance assignments are indicated for the spectrum recorded in the presence of 1. The star identifies a peak
that could not be attributed to any of the isoleucines in the protease. Its relatively narrow line shape suggests its origin from a low-molecular weight
impurity. (B) Locations of the isoleucine residues in the crystal structure of the WNV NS2B-NS3 protease (PDB code 2IJO). The nitrogen atoms are
drawn as balls, using blue and red colour to identify the residues with, respectively, little and large spectral changes in the
15N-HSQC spectra caused
by 1. NS2B is shown in magenta and its N- and C-termini are identified. The isoleucine residues of NS2B are labeled in italics. The arrow identifies the
site of Cys89 in NS2B-NS3pro
C. (C) Same as (B), except for the open conformation (PDB code 2GGV). Only the isoleucine residues of NS2B are labeled
for improved visual presentation. (D) Same as (B), except that results obtained with uniformly
15N-labeled WNV NS2B-NS3pro are displayed by
highlighting selected backbone nitrogens. Red:
15N-HSQC cross-peaks were assigned in the presence of inhibitor but seem to be missing in the
absence of inhibitor. Yellow:
15N-HSQC cross-peaks shifting more than 0.05 ppm in the
1H dimension between the spectra recorded with and without
inhibitor 1. Blue:
15N-HSQC cross-peaks shifting less than 0.02 ppm in the
1H dimension between spectra with and without inhibitor.
doi:10.1371/journal.pntd.0000561.g003
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NS3 were observable both with and without inhibitor. Therefore,
mobility of the side-chain of the active-site histidine, His51, that
was reported in a recent crystallographic analysis [8] or other
conformational changes in the active site cannot be the cause of
the excessive line broadening observed in the absence of
inhibitors.
Dissociation of the NS2B CTS from NS3 thus is the main cause
for the observed broadening and absence of cross-peaks in the
protease without inhibitor. Nonetheless, the NS2B CTS does not
exclusively populate a highly mobile random coil conformation
(which would result in very narrow peaks) but interacts at least to
some extent with NS3.
15N-Relaxation Measurements
The flexibility of the polypeptide chain on the subnanosecond
time scale was probed by measurement of the R2(
15N) relaxation
rates of uniformly
15N-labeled NS2B-NS3pro. The average
relaxation rate was slightly higher in the absence of inhibitor,
which may reflect a greater tendency for aggregation (Figure 4).
Only the residues C-terminal of Glu173
NS3 displayed relaxation
rates characteristic of a highly mobile random-coil peptide. In
contrast, as far as the relaxation rates of NS2B could be assessed,
they were similar to those of NS3, both in the absence and
presence of inhibitor, suggesting continuous association between
the N-terminal segment of NS2B until Ser72
NS2B and NS3. In the
presence of 1, the NS2B CTS displayed some of the largest R2
values, suggesting that the inhibitor did not completely suppress
the chemical exchange. Finally, at least ten of the linker residues
tethering the C-terminus of NS2B to the N-terminus of NS3 (not
shown in Figure 4 due to missing sequence specific assignments)
displayed R2 relaxation rates characteristic of highly mobile
segments (below 10 s
21), regardless of the presence or absence of
inhibitor. This indicates that the peptide linker between NS2B and
NS3 presents little hindrance for the dissociation of the NS2B CTS
from NS3.
Paramagnetic Relaxation Enhancements
In order to gain more insight into possible conformational
equilibria of the NS2B CTS, we used NS2B-NS3pro
C with an
MTSL spin-label at Cys89 (location shown in Figures 3B and C
and 5D–F). As wild-type WNV NS3pro contains a buried cysteine
residue at position 78, we also tested the reactivity of Cys78 in a
control experiment by treating wild-type NS2B-NS3pro with
MTSL under the same reaction conditions. Analysis by
15N-
HSQC spectra showed that the cross-peak of Cys78 did not shift
or change in intensity, confirming its inaccessibility to MTSL
(Figure S1). As expected for a residue without specific long-range
contacts, the N89C mutation did not affect the structural integrity
of the protease as evidenced by the close similarity of the
15N-
HSQC spectra of NS2B-NS3pro and NS2B-NS3pro
C except for
sequential neighbours of residue 89 (data not shown).
Figure 5A shows the results of the spin-labeling experiment.
Different
15N-HSQC cross-peaks were attenuated differently by
the paramagnetic spin-label in a way that is much more readily
explained by the closed conformation of Figure 1A (Figure 5B)
than the open conformation of Figure 1B (Figure 5C). In
particular, the signal attenuations near Cys89
NS2B and Ser160
NS3
were similarly pronounced, indicating that the closed conforma-
tion is the predominant species both in the presence and absence
of the inhibitor 2. There were, however, also significant differences
between the paramagnetic attenuations observed in the presence
and absence of the inhibitor 2 (Figure 5D and E) which must arise
either from minor conformational species or from intermolecular
effects.
In order to assess possible intermolecular effects, we evaluated
the signal attenuations at two different concentrations (Figure S2).
A pronounced concentration dependence was observed for the
exposed loop region with residues 29–32 and nearby residues (e.g.
Gly103), indicating that these regions were significantly affected by
intermolecular effects, partly or wholly explaining the apparent
discrepancies between the plots of Figure 5D and E for those
residues. An increased tendency for intermolecular aggregation in
Figure 4. Protein flexibility probed by transverse
15N relaxation rates R2. The data were measured using a 0.9 mM solution of
15N/
13C-
labeled NS2B-NS3pro in the presence (black triangles) and absence (red squares) of 3 mM 2. Data points are plotted versus residue number and
connected by lines for improved visual appearance. For NS3, data are shown only for residues for which R2 data could be measured in both states. All
points are shown for NS2B in the presence of the inhibitor 2 as a guide for the mobility of the NS2B CTS. Error bars show the error reported by the
fitting routine in Sparky [21].
doi:10.1371/journal.pntd.0000561.g004
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crystal structures of WNV NS2B-NS3pro. (A) Relative peak intensities observed in
15N-HSQC spectra of WNV NS2B-NS3pro
C with MTSL versus
those of WNV NS2B-NS3pro
C without spin-label. In order to adjust for uncertainties in protein concentration, the intensity ratios were normalized by
setting the largest Ipara/Idia ratio to 1. The black and red data points were measured in the presence and absence of inhibitor 2, respectively. (B)
Distance between the N89C
a (as a proxy for the position of the spin-label) and the amide nitrogens in the closed conformation (PDB code 2IJO). (C)
Same as (B), except for the open conformation (PDB code 2GGV). (D) Plot of the data in (A), as obtained without inhibitor, on the closed conformation
of the WNV NS2B-NS3 protease (PDB code 2IJO). NS2B is shown in magenta. The position of Cys89 in WNV NS2B-NS3pro
C carrying the spin-label is
identified by an arrow. Amide protons are highlighted with spheres of different colour depending on the Ipara/Idia ratio in (A): 0–0.2 (red), 0.2–0.4
(pink), 0.4–0.6 (yellow), 0.6–0.8 (cyan), 0.8–1.0 (blue). (E) Same as (D), but for the data in the presence of inhibitor 2. (F) Stereoview of the closed
conformation in the representation of (D) and (E). Red spheres identify amide protons of residues for which small concentration dependence in the
absence of inhibitor indicates intramolecular PRE effects. Pink spheres identify the location of amide protons for which PRE were significantly
concentration dependent, indicating an intermolecular PRE mechanism. NS2B residues are marked in italics.
doi:10.1371/journal.pntd.0000561.g005
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15N) data (Figure 4)
also explains why the PRE effects of these residues are greater in
the absence of inhibitor (Figure 5A).
The PRE effects of at least four residues (Thr50
NS2B,
Arg56
NS2B, Gly63
NS3 and Trp89
NS3) are pronounced in the
absence of inhibitor, depend only little on concentration and
cannot be explained by the closed conformation (Figure 5F). We
interpret those as intramolecular effects caused by minor
conformational species resulting from transient dissociation of
the CTS of NS2B from NS3pro. These open conformations must
be more heterogeneous than the open conformation of Figure 1B.
The relaxation enhancements of all four residues were significantly
less pronounced in the presence of inhibitor (Figure 5A), indicating
stabilization of the closed conformation by the inhibitor.
Therefore, the PRE data support the notion of an equilibrium
between a major conformation corresponding to the closed
conformation of Figure 1A and an ensemble of transient open
conformations that are generally different from the conformation
of Figure 1B. Inhibitors shift the equilibrium towards the closed
conformation but the equilibrium persists to some extent also in
the presence of inhibitors.
Discussion
The very different folds observed for NS2B in the WNV and
DENV NS2B-NS3 protease crystal structures in the presence and
absence of inhibitors raise the question of their relative abundance
in solution and under in vivo conditions, with important
implications for the function of these proteases. The present work
attributes the extreme broadening of many NMR signals in the
absence of inhibitors to the equilibrium between different
conformations of NS2B rather than to conformational equilibria
restricted to the active-site pocket. As the amide cross-peaks of
some of the active-site residues remain unobservable in the
presence of inhibitors [17], complete suppression of the confor-
mational exchange in the active-site pocket appears to be more
difficult to achieve.
Release of the binding interaction between the CTS of NS2B
and NS3pro has implications for the proteolytic activity near the
host cell membrane and for drug molecules designed to inhibit
proteolytic activity by interfering with the correct association of the
NS2B cofactor to NS3.
Implications for Proteolytic Activity near the Host Cell
Membrane
The wild-type WNV polyprotein is associated with the host cell
membrane. Also after proteolytic processing of the polyprotein, the
NS2B-NS3 protease remains membrane associated via two
transmembrane helices N-terminal of the NS2B cofactor part
displayed in Figure 1A and B. In addition, the C-terminus of the
NS2B cofactor is connected to NS3 by a highly hydrophobic
segment of 35 residues [1] (replaced by a Gly4-Ser-Gly4 linker in
our construct) that is also thought to insert into the host cell
membrane [22,23]. This ties the NS2B cofactor to the membrane
at either end. Auto-proteolytic cleavage occuring near Lys96
NS2B
and Lys15
NS3 excises the segment between NS2B and NS3 in vitro
[7,17] but does not affect the N-terminal membrane attachment.
As the cleavage site near Lys96
NS2B lacks the characteristic
recognition sequence of two sequentially neighboring basic
residues and is also not conserved in the highly homologous
dengue virus NS2B-NS3 protease, cleavage at this site may be
inefficient, in which case NS2B would remain tethered to the host
cell membrane at either end. Independent of whether the NS2B
cofactor is tied to the membrane at one or both ends, there is no
reason why the association of NS3pro with the NS2B CTS should
be any tighter than that observed in the model system studied
here, once the covalent linkage between NS2B and NS3 has been
broken.
The association between NS2B and NS3pro appears to be
independent of the helicase domain of NS3. In the crystal structure
of a DENV NS2B-NS3 construct comprising both the protease
and helicase domains of NS3, the interface is centered about
residue 68 of the NS3, displacing the N-terminal b-strand of NS3
observed in the structure 2IJO (dark blue in Figure 1A), and the
helicase domain makes no contacts with NS2B or the substrate
binding site [24]. The same arguments apply to the WNV
homologue [22,23]. It is not clear, however, whether the crystal
structure of the DENV NS3 protease-helicase construct is a good
model for membrane-associated NS2B-NS3 as it suggests that the
helicase domain clashes with the membrane when both ends of
NS2B are tied to a planar lipid bilayer.
If the NS3 helicase domain is only loosely associated with the
NS3 protease domain, the NS3 protease domain could dissociate
from the NS2B CTS to access substrate cleavage sites further away
from the membrane surface, although the separation from the
NS2B CTS would simultaneously impede its proteolytic activity.
The NS2B CTS could, however, follow the NS3 protease domain
if its C-terminal membrane attachment is broken by cleavage at
the non-canonical site near Lys96
NS2B, generating a catalytically
active NS3 protease that is anchored to the membrane only at the
NS2B N-terminus.
Populations of Different Conformations
The present work shows that, in solution, the closed
conformation (or a closely related conformation) is predominantly
populated even in the absence of inhibitors. The strongest
evidence for this conclusion comes from the similarity of the
15N-relaxation with and without inhibitor and from the close
similarity between the paramagnetic relaxation enhancements of
residues 147–170 with and without inhibitor (Figure 5A). In
addition, the PREs indicate that the open conformations detected
by the spin-labeling experiment are mostly unrelated to those
found in the crystal structures of the WNV and dengue NS2B-NS3
proteases. As PREs strongly depend on the distance from the spin
label, they enable the detection of minor conformational species
which may be populated by as little as 1%.
The exchange broadening observed for many NMR resonances
is also in agreement with the closed conformation as the major
species. Chemical exchange of a major conformational species
with one or several minor species populated by as little as 5% can
lead to the disappearance of cross-peaks if the exchange rate is
comparable to the difference in chemical shifts of the conforma-
tional states. The appearance of all cross-peaks in the presence of
inhibitors can thus be explained, if the inhibitor shifts the
conformational equilibrium towards a single conformation (pop-
ulated by at least 90%). The alternative explanation of a greatly
accelerated exchange rate leading to recovery of the cross-peaks is
unlikely, as it is difficult to imagine a mechanism by which a low-
molecular weight inhibitor would accelerate a major conforma-
tional exchange process in the protein.
Considering that inhibitors 1 and 2 do not form van der Waals
contacts with NS2B [14,18], the shift in equilibrium may result
from attractive electrostatic interactions with the b-hairpin of the
NS2B CTS that carries a sequence of three Asp residues
(Asp80
NS2B-Asp82
NS2B). Available structures show that inhibitors
1 and 2 [18], BPTI [6] and peptide inhibitors [7,8] all project
positively charged groups towards the b-hairpin of the NS2B CTS.
The importance of electrostatic interactions for enzymatic activity
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that increasing concentrations of NaCl decrease enzymatic activity
[16].
Effect of the Linker between NS2B and NS3
All available observations indicate that the structural association
of the NS2B CTS with NS3pro is not an artifact of the covalent
linker connecting the C-terminus of NS2B with the N-terminus of
NS3. (i) R2 relaxation rates show that at least ten of the linker
residues are highly mobile regardless of the presence or absence of
inhibitor. (ii) NMR spectra of wt NS2B-NS3 without this covalent
link showed no evidence of increased flexibility of the NS2B CTS
regardless of the presence of inhibitor (data not shown). (iii) The
association of the NS2B CTS with NS3pro is structurally
conserved between all three crystal structures of the WNV
NS2B-NS3 protease in complexes with different inhibitors,
independent of the presence or absence of the linker and for
different linker lengths [6–8]. All three structures shown in Figure 1
were crystallized with uncleaved linker peptides present, illustrat-
ing the freedom of the NS2B CTS to assume the different
conformations consistently despite the linker. (iv) Shortening of the
linker sequence between NS2B and NS3 by one Gly residue has
been shown not to affect the proteolytic activity of the WNV
protease [5]. (v) The construct of the DENV NS2B-NS3
homologue used previously for crystallization [7] contained the
same number of residues and the Gly4-Ser-Gly4 segment as the
linker peptide in the WNV NS2B-NS3pro construct without
preventing enhanced flexibility of the NS2B CTS (see below).
Comparison with DENV NS2B-NS3 and Implications for
Drug Design
Comparison of the present results with previous NMR data of a
15N/
13C-Ile labeled sample of the dengue virus type 2 NS2B-NS3
protease [25] reveals an unexpected important difference. In the
case of the DENV protease, in the absence of inhibitor, the
15N-
HSQC cross-peaks of all five isoleucine residues spanning NS2B
from Ile67 to Ile86 appeared at random coil chemical shifts and
displayed much narrower line widths than any isoleucine residue
in the structured core of NS3pro [25]. The absence of any line
broadening in this segment indicates that it is more than 90% of
the time dissociated from NS3pro. Nonetheless, the NS2B CTS
seems to affect the NMR line widths in the rest of the protein, as
much more uniform NMR peak intensities have been reported
following cleavage of recombinant NS2B-NS3 protease at
Asp81
NS2B by endoprotease Asp-N [26].
The association of NS2B to NS3 has important implications for
structure-based drug design. First, if the NS2B CTS remains
largely dissociated also in the presence of inhibitors, this may
explain the persistent difficulties to crystallize the dengue virus
enzyme with a bound inhibitor. Second, the relatively close
association of the NS2B CTS with NS3 in the case of the WNV
NS2B-NS3 protease may make it harder to find inhibitors that
suppress the protease activity by preventing the association of the
NS2B CTS with NS3pro. In contrast, the closed conformation is
an appropriate target for rational drug design and has already
been used successfully to identify hits by virtual screening [14,15].
Supporting Information
Figure S1
15N-HSQC spectra of 0.3 mM solutions of
15N-
labeled WNV NS2B-NS3pro(N89C,K96A) with and without
MTSL and in the absence and presence of 3 mM 2. Superim-
position of
15N-HSQC spectra of WNV NS2B-NS3pro
C without
(blue spectrum) and with MTSL bound to Cys89 (magenta
spectrum) in the (A) absence and (B) presence of the inhibitor 2.
The samples contained 0.3 mM protein in 90% H2O/10% D2O
containing 20 mM Tris buffer (pH 7.2) and 2 mM DTT. The
spectra were recorded at 25uC on an 800 MHz NMR spectrom-
eter. The complexes with 2 were prepared by adding 3 mlo fa
100 mM stock solution of 2 in d6-DMSO to the protein solution.
Resolved cross-peaks are labelled, if they showed significant
differences in peak intensities between the samples with and
without MTSL. Cross-peaks from NS2B are labelled in italics. A
box highlights the cross-peak of Cys78 which is not attenuated by
the spin label, demonstrating that this buried cysteine residue did
not react with MTSL.
Found at: doi:10.1371/journal.pntd.0000561.s001 (0.86 MB PDF)
Figure S2 Concentration dependence of the ratio of
15N-HSQC
peak heights observed for WNV NS2B-NS3pro
C with MTSL
versus those of unmodified WNV NS2B-NS3pro
C. Concentration
dependence of the ratio of
15N-HSQC peak heights observed for
WNV NS2B-NS3pro
C with MTSL versus those of unmodified
WNV NS2B-NS3pro
C. In order to adjust for differences in protein
concentration, scan numbers and receiver gains, the intensity
ratios were normalized by setting the largest Ipara/Idia ratio to 1.
(A) In the absence of inhibitor. Black squares: 0.26 mM protein.
Red circles: 0.13 mM protein. The diamagnetic reference is the
0.26 mM protein in both cases. (B) In the presence of inhibitor 2.
Black squares: 0.26 mM protein with 0.6 mM 2. Red circles:
0.13 mM protein with 0.26 mM 2. In both cases, the diamagnetic
reference is 0.26 mM protein in the presence of 0.6 mM 2.
Found at: doi:10.1371/journal.pntd.0000561.s002 (0.53 MB PDF)
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